| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 621.124 | 93 |
| GSM780708 | Untreated after 4 days (C2_1) | 630.286 | 93 |
| GSM780709 | Untreated after 4 days (C3_1) | 614.998 | 93 |
| GSM780719 | Untreated after 4 days (C1_2) | 565.376 | 92 |
| GSM780720 | Untreated after 4 days (C2_2) | 591.087 | 93 |
| GSM780721 | Untreated after 4 days (C3_2) | 580.361 | 93 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 654.849 | 93 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 591.087 | 93 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 661.124 | 93 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 613.033 | 93 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 558.155 | 92 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 521.094 | 92 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 505.47 | 92 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 663.893 | 93 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 615.169 | 93 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 498.318 | 92 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 552.273 | 92 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 560.106 | 92 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 642.104 | 93 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 594.108 | 93 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 637.8 | 93 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 612.807 | 93 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 672.227 | 93 |